Diagnostic tests can identify a distinct subset of patients with glaucoma and other developmental disorders as well as those at risk of developing glaucoma.
Experimental assays can facilitate the identification of preventive or therapeutic agents.
The development of a method for treating glaucoma by gene therapy can now be explored. Potential Markets Health care companies can use this discovery to develop mutation-screening kits, therapeutic agents, and therapies that health care workers can use in diagnosing and treating patients with glaucoma and other developmental disorders.